DO YOU HAVE TO LIE TO INDUCE PLACEBO EFFECTS?: The use of open label placebos in sport and exercise

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR AND FRANCIS
Citação
Saunders, B.; Marticorena, F. M.; Gualano, B.. DO YOU HAVE TO LIE TO INDUCE PLACEBO EFFECTS?: The use of open label placebos in sport and exercise. In: . Placebo Effects in Sport and Exercise: TAYLOR AND FRANCIS, 2023. p.133-143.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The use of deceptive placebo in practice is inherently fraught with ethical constraints and trust issues, meaning that alternative methods must be employed in practice. This has led to the development of an alternative approach through which placebo effects might be generated, namely open-label placebo (also called “honest placebo”). This method consists of openly informing the individual that they are receiving an inert intervention (i.e., a placebo). While there is a growing body of evidence demonstrating the efficacy of this method in clinical practice, data in sport and exercise remain scarce. In this chapter, we discuss the use of open-label placebo as a potential ergogenic intervention in the context of exercise and sports, we propose theoretical mechanisms through which they work, and we place an emphasis on practical applications and research gaps in this emerging area of research. © 2024 selection and editorial matter, Philip Hurst and Chris Beedie; individual chapters, the contributors.
Palavras-chave
Referências
  1. Barreto G., Saito T., Oliveira L.F., Grecco B., Oliveira T.N., Merola P., Carvalho A., Gualano B., Saunders B., Apparent sex-differences on the effects of an open-placebo intervention on 4-km time trial performance in trained cyclists, 3rd International Conference of The Society for Interdisciplinary Placebo Studies (SIPS2021) conference, (2021)
  2. Beedie C., Benedetti F., Barbiani D., Camerone E., Cohen E., Coleman D., Davis A., Elsworth-Edelsten C., Flowers E., Foad A., Consensus statement on placebo effects in sports and exercise: The need for conceptual clarity, methodological rigour, and the elucidation of neurobiological mechanisms, European Journal of Sport Science, 18, 10, pp. 1383-1389, (2018)
  3. Beedie C.J., Foad A.J., The placebo effect in sports performance: A brief review, Sports Medicine, 39, pp. 313-329, (2009)
  4. Benedetti F., Mayberg H.S., Wager T.D., Stohler C.S., Zubieta J.-K., Neurobiological mechanisms of the placebo effect, Journal of Neuroscience, 25, 45, pp. 10390-10402, (2005)
  5. Benedetti F., Pollo A., Colloca L., Opioid-mediated placebo responses boost pain endurance and physical performance: Is it doping in sport competitions?, Journal of Neuroscience, 27, 44, pp. 11934-11939, (2007)
  6. Canestri R., Franco-Alvarenga P.E., Brietzke C., Vinicius I., Smith S.A., Mauger A.R., Goethel M.F., Pires F.O., Effects of experimentally induced muscle pain on endurance performance: A proof-of-concept study assessing neurophysiological and perceptual responses, Psychophysiology, 58, 6, (2021)
  7. Corbett J., Barwood M.J., Ouzounoglou A., Thelwell R., Dicks M., Influence of competition on performance and pacing during cycling exercise, Medicine & Science in Sports & Exercise, 44, 3, pp. 509-515, (2012)
  8. Davis A.J., Hettinga F., Beedie C., You don’t need to administer a placebo to elicit a placebo effect: Social factors trigger neurobiological pathways to enhance sports performance, European Journal of Sport Science, 20, 3, pp. 302-312, (2020)
  9. Davis J.M., Zhao Z., Stock H.S., Mehl K.A., Buggy J., Hand G.A., Central nervous system effects of caffeine and adenosine on fatigue, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 284, 2, pp. R399-R404, (2003)
  10. De Craen A.J., Roos P.J., De Vries A.L., Kleijnen J., Effect of colour of drugs: Systematic review of perceived effect of drugs and of their effectiveness, BMJ, 313, 7072, pp. 1624-1626, (1996)
  11. de la Fuente-Fernandez R., Schulzer M., Stoessl A.J., The placebo effect in neurological disorders, The Lancet Neurology, 1, 2, pp. 85-91, (2002)
  12. Finniss D.G., Kaptchuk T.J., Miller F., Benedetti F., Biological, clinical, and ethical advances of placebo effects, The Lancet, 375, 9715, pp. 686-695, (2010)
  13. Flowers K.M., Patton M.E., Hruschak V.J., Fields K.G., Schwartz E., Zeballos J., Kang J.D., Edwards R.R., Kaptchuk T.J., Schreiber K.L., Conditioned open-label placebo for opioid reduction after spine surgery: A randomized controlled trial, Pain, 162, 6, (2021)
  14. Fredholm B.B., Riksen N.P., Smits P., Rongen G.A., The cardiovascular effects of methylxanthines, Methylxanthines, pp. 413-437, (2011)
  15. Grotle M., Hagen K.B., Placebo pills provided without deception may help to reduce pain and disability in people with chronic low back pain [synopsis], Journal of Physiotherapy, 63, 3, (2017)
  16. Guevarra D.A., Moser J.S., Wager T.D., Kross E., Placebos without deception reduce self-report and neural measures of emotional distress, Nature Communications, 11, 1, (2020)
  17. Hoenemeyer T.W., Kaptchuk T.J., Mehta T.S., Fontaine K.R., Open-label placebo treatment for cancer-related fatigue: A randomized-controlled clinical trial, Scientific Reports, 8, 1, (2018)
  18. Hurst P., Schipof-Godart L., Szabo A., Raglin J., Hettinga F., Roelands B., Lane A., Foad A., Coleman D., Beedie C., The placebo and nocebo effect on sports performance: A systematic review, European Journal of Sport Science, 20, 3, pp. 279-292, (2020)
  19. Jarcho J.M., Feier N.A., Labus J.S., Naliboff B., Smith S.R., Hong J.-Y., Colloca L., Tillisch K., Mandelkern M.A., Mayer E.A., Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response, NeuroImage: Clinical, 10, pp. 107-114, (2016)
  20. Kaptchuk T.J., Friedlander E., Kelley J.M., Sanchez M.N., Kokkotou E., Singer J.P., Kowalczykowski M., Miller F.G., Kirsch I., Lembo A.J., Placebos without deception: A randomized controlled trial in irritable bowel syndrome, PLoS One, 5, 12, (2010)
  21. Kelley J.M., Kaptchuk T.J., Cusin C., Lipkin S., Fava M., Open-label placebo for major depressive disorder: A pilot randomized controlled trial, Psychotherapy and Psychosomatics, 81, 5, pp. 312-314, (2012)
  22. Khan S.I., McNeil C.J., Gandevia S.C., Taylor J.L., Effect of experimental muscle pain on maximal voluntary activation of human biceps brachii muscle, Journal of Applied Physiology, 111, 3, pp. 743-750, (2011)
  23. Lidstone S.C., Schulzer M., Dinelle K., Mak E., Sossi V., Ruth T.J., de la Fuente-Fernandez R., Phillips A.G., Stoessl A.J., Effects of expectation on placebo-induced dopamine release in Parkinson disease, Archives of General Psychiatry, 67, 8, pp. 857-865, (2010)
  24. Marticorena F.M., Carvalho A., de Oliveira L.F., Dolan E., Gualano B., Swinton P., Saunders B., Nonplacebo controls to determine the magnitude of ergogenic interventions: A systematic review and meta-analysis, Medicine and Science in Sports and Exercise, 53, 8, pp. 1766-1777, (2021)
  25. Miller F.G., Colloca L., The legitimacy of placebo treatments in clinical practice: Evidence and ethics, The American Journal of Bioethics, 9, 12, pp. 39-47, (2009)
  26. Noakes T.D., St Clair Gibson A., Lambert E.V., From catastrophe to complexity: A novel model of integrative central neural regulation of effort and fatigue during exercise in humans: Summary and conclusions, British Journal of Sports Medicine, 39, 2, pp. 120-124, (2005)
  27. Rossow L.M., Moon J., Hiebert L., Espitia C., Fahs C.A., The effects of honest and dishonest placebo ingestion immediately prior to VO2peak and handgrip strength testing, Journal of Trainology, 8, 2, pp. 27-30, (2019)
  28. Saito T., Barreto G., Saunders B., Gualano B., Is open-label placebo a new ergogenic aid? A commentary on existing studies and guidelines for future research, Sports Medicine, 50, 7, pp. 1225-1229, (2020)
  29. Saunders B., Saito T., Klosterhoff R., de Oliveira L.F., Barreto G., Perim P., Pinto A.J., Lima F., de Sa Pinto A.L., Gualano B., “I put it in my head that the supplement would help me”: Open-placebo improves exercise performance in female cyclists, PLoS One, 14, 9, (2019)
  30. Schaefer M., Harke R., Denke C., Open-label placebos improve symptoms in allergic rhinitis: A randomized controlled trial, Psychotherapy and Psychosomatics, 85, 6, pp. 373-375, (2016)
  31. Schaefer M., Sahin T., Berstecher B., Why do open-placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis, PLoS One, 13, 3, (2018)
  32. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.-K., Individual differences in reward responding explain placebo-induced expectations and effects, Neuron, 55, 2, pp. 325-336, (2007)
  33. Stefano G.B., Fricchione G.L., Slingsby B.T., Benson H., The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide, Brain Research Reviews, 35, 1, pp. 1-19, (2001)
  34. Swafford A.P., Kwon D.P., MacLennan R.J., Fukuda D.H., Stout J.R., Stock M.S., No acute effects of placebo or open-label placebo treatments on strength, voluntary activation, and neuromuscular fatigue, European Journal of Applied Physiology, 119, pp. 2327-2338, (2019)
  35. Swinton P.A., Hemingway B.S., Saunders B., Gualano B., Dolan E., A statistical framework to interpret individual response to intervention: Paving the way for personalized nutrition and exercise prescription, Frontiers in Nutrition, 5, (2018)
  36. Van Soeren M., Sathasivam P., Spriet L., Graham T., Caffeine metabolism and epinephrine responses during exercise in users and nonusers, Journal of Applied Physiology, 75, 2, pp. 805-812, (1993)
  37. Zhou E.S., Hall K.T., Michaud A.L., Blackmon J.E., Partridge A.H., Recklitis C.J., Open-label placebo reduces fatigue in cancer survivors: A randomized trial, Supportive Care in Cancer, 27, pp. 2179-2187, (2019)